Correlation Between Entrada Therapeutics and Wise Plc

Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and Wise Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and Wise Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entrada Therapeutics and Wise plc, you can compare the effects of market volatilities on Entrada Therapeutics and Wise Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of Wise Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and Wise Plc.

Diversification Opportunities for Entrada Therapeutics and Wise Plc

0.68

Correlation Coefficient

Entrada Therapeutics  Wise Plc

Poor diversification

The 3 months correlation between Entrada and Wise is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and Wise plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wise plc and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with Wise Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wise plc has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and Wise Plc go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and Wise Plc

Given the investment horizon of 90 days Entrada Therapeutics is expected to under-perform the Wise Plc. In addition to that, Entrada Therapeutics is 1.94 times more volatile than Wise plc. It trades about -0.02 of its total potential returns per unit of risk. Wise plc is currently generating about 0.47 per unit of volatility. If you would invest  1,104  in Wise plc on September 22, 2024 and sell it today you would earn a total of  217.00  from holding Wise plc or generate 19.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Entrada Therapeutics  vs.  Wise plc

Entrada Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Wise plc

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Wise plc are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Wise Plc showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Entrada Therapeutics and Wise Plc

The main advantage of trading using opposite Entrada Therapeutics and Wise Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, Wise Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wise Plc will offset losses from the drop in Wise Plc's long position.

The idea behind Entrada Therapeutics and Wise plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.